• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

	Semnur Pharmaceuticals, Inc. (DECA)
	Q1-CY2026	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014	Q1-CY2014
Balance Sheet Date		2025-Dec-31	2025-Sep-30	2025-Jun-30	2025-Mar-31	2024-Dec-31	2024-Sep-30	2024-Jun-30	2024-Mar-31	2023-Dec-31
Fiscal Period		Q4-FY2025	Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024	Q3-FY2024	Q2-FY2024	Q1-FY2024	Q4-FY2023
Total Assets		1,346,000$	774,000$	562,462$	9,147,903$	6,684,000$	8,924,547$	52,115,789$	51,347,261$	50,687,403$				86,279,436$
Total Current Assets		596,000$	85,000$	14,144$	2,736$	5,995,000$	35,428$	43,783$	65,412$	209,440$				907,836$
Cash and Cash Equivalents		20,000$	85,000$			12,000$			1,013$	204,464$				819,747$
Receivables
Other Current Assets						5,981,000$
Assets Held for Sale in Short Term
Total Noncurrent Assets		750,000$	689,000$	548,318$	9,145,167$	689,000$	8,889,119$	52,072,006$	51,281,849$	50,477,963$				85,371,600$
Goodwill
Other Intangible Assets
Physical Assets		750,000$	689,000$			689,000$
Other Noncurrent Assets
Assets Held for Sale in Long Term
Total Liabilities		22,096,000$	15,367,000$	11,156,451$	10,739,217$	49,468,000$	9,481,571$	9,206,623$	8,887,007$	8,491,480$				4,179,141$
Total Current Liabilities		10,168,000$	10,032,000$	8,268,951$	7,851,717$	35,000$	6,594,071$	6,319,123$	5,999,507$	5,603,980$				1,291,641$
Accounts Payable		5,912,000$	4,288,000$
Short Term Debt
Short Term Capital Lease Obligations
Other Current Liabilities		4,000$	22,000$	78,224$	68,351$	25,000$	48,605$	38,624$	28,751$	18,878$
Total Noncurrent Liabilities		11,928,000$	5,335,000$	2,887,500$	2,887,500$	49,433,000$	2,887,500$	2,887,500$	2,887,500$	2,887,500$				2,887,500$
Long Term Debt
Long Term Capital Lease Obligations
Other Noncurrent Liabilities
Total Equity		(20,750,000$)	(14,593,000$)	(44,448,000$)	(43,449,000$)	(42,784,000$)	(42,008,000$)	(40,710,000$)	(39,600,000$)	(38,094,000$)	(7,931,846$)	(6,586,203$)	(5,193,053$)	(3,271,305$)
Equity to Minority
Equity to Common Shareholders		(20,750,000$)	(14,593,000$)	(44,448,000$)	(43,449,000$)	(42,784,000$)	(42,008,000$)	(40,710,000$)	(39,600,000$)	(38,094,000$)	(7,931,846$)	(6,586,203$)	(5,193,053$)	(3,271,305$)
Additional Paid-In Capital		255,026,000$	255,025,000$			72,580,000$
Retained Earnings		(275,800,000$)	(269,642,000$)	(11,142,564$)	(10,736,738$)	(115,384,000$)	(9,446,400$)	(9,163,097$)	(8,821,852$)	(8,282,297$)				(3,271,562$)
Treasury Stock
Capital Lease Obligations

Copy Table ✓